期刊文献+

依那普利联合不同药物治疗慢性肾小球肾炎疗效分析 被引量:7

Effect analysis of enalapril combined with different drugs in the treatment of chronic glomerular nephritis
下载PDF
导出
摘要 目的探讨依那普利联合不同药物治疗慢性肾小球肾炎的治疗效果。方法选择笔者所在医院收治的82例慢性肾小球肾炎患者的临床资料,随机分为观察组和对照组各41例,观察组采用口服依那普利联合静脉滴注灯盏细辛注射液进行治疗;对照组采用口服依那普利联合静脉滴注阿魏酸钠注射液进行治疗。结果观察组的总有效率和显效率均明显高于对照组,差异有统计学意义(P<0.05)。结论依那普利联合灯盏细辛注射液在治疗慢性肾小球肾炎的疗效方面明显优于依那普利联合阿魏酸钠注射液,值得在临床上推广应用。 Objective To study the effect of enalapril combined with different drugs in the treatment of chronic glomerulonephritis. Methods 82 cases of chronic glomerular nephritis were divided into the observation group and the control group with 41 cases in each group,the observation group was treated with oral administration of enalapril combined with intravenous injection of Erigeron breviscapus injection for treatment;the control group with oral administration of enalapril combined with intravenous infusion of sodium ferulate injection. Results The total efficiency and effective rate of the observation group were obviously higher than that of the control group,the difference was statistically significant (P 〈 0.05). Conclusion Enalapril combined with Fleabane injection in the treatment of chronic glomerular nephritis were better than those of enalapril combined with sodium ferulate injection,worthy of clinical promotion and application.
出处 《中国医药科学》 2012年第8期38-39,共2页 China Medicine And Pharmacy
关键词 依那普利 灯盏细辛注射液 阿魏酸钠注射液 慢性肾小球肾炎 Enalapril Erigeron injection Sodium ferulate injection Chronic glomerulonephritis
  • 相关文献

参考文献5

二级参考文献22

  • 1吴永贵,林辉,钱浩,赵珉,戴宏,郝丽,张伯科.灯盏花素与LY333531对糖尿病大鼠肾脏的保护作用[J].中华肾脏病杂志,2004,20(6):429-433. 被引量:39
  • 2李慧侠,殷扬.灯盏细辛在心血管疾病和肾病治疗中的临床应用[J].华北煤炭医学院学报,2005,7(4):476-477. 被引量:2
  • 3许增禄.显示胶原及其类型的苦味酸天狼星红─偏振光方法[J].基础医学与临床,1996,16(1):75-76. 被引量:22
  • 4余传龙 黄泰康 丁志遵.中药辞海[M].北京:中国医药科技出版社,1993.2290.
  • 5国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:85-89.
  • 6Hwang M, Kim HJ, Noh HJ, et al. TGF-betal siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006 ;81 ( 1 ) : 48-54.
  • 7Zeisberg M, Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 2000 ; 13 ( Suppl 3 ) : s111-s120.
  • 8Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001 ; 159(4): 1465-1475.
  • 9Jinde K, Nikolic-Paterson DJ, Huang XR, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001 ;38(4) : 761-769.
  • 10Goumenos DS, Tsamandas AC, Oldroyd S, et al. Transforming growth factor-beta ( 1 ) and myofibroblasts : a potential pathway towards renal scarring in human glomendar disease. Nephron 2001 ;87 ( 3 ) : 240-248.

共引文献21

同被引文献49

  • 1谭洪华,李霞,薄爱华.原发性肾小球肾炎发病机制研究进展[J].河北北方学院学报(医学版),2006,23(1):76-78. 被引量:6
  • 2吴锦美.黄葵胶囊治疗慢性肾炎50例疗效观察[J].现代中西医结合杂志,2007,16(8):1064-1065. 被引量:15
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,2001.953.
  • 4陆再英.内科学[M].7版.北京:人民卫生出版社,2011:936.
  • 5饶向荣.肾小球肾炎[M].北京:科学技术文献出版社,1999:163-184.
  • 6张伯臾.中医内科科学[M].1版.上海:上海科学技术出版社,1984:227.
  • 7Guo, S. , Kowalewska, J. , Wietecha, T. A. , et al. Renin-angiotensin system blockade is renoproteetive in immune complex-mediate dolomerulo nephritis [J]. J Am Soc Nephrology, 2012,19 ( 6 ) : 1168 - 1176.
  • 8Tanaka, H. , Suzuki, K. , Nakahata, T. , et al. Combined therapy of enalapril and losartan attenuates histological progression in immunoglobulin a nephropathy [ J ]. Pediatric Int, 2012,46 ( 5 ) : 576 - 579.
  • 9Nagano M, Fukami K, Yamagishi S,et al. Circulating matrixmetallo- proteinase- 2 is an independent correlate of proteinuriain patients with chronic kidney disease [ J ]. Am J Nephrol,2009,29 : 109 - 115.
  • 10Tan TK,Zheng G,Hsu TT,et al. Macrophage matrix metalloprotein- ase -9 mediates epithelial-mesenchymal transitionin vitro in routine renal tubular ceils[ J]. Am J Pathol,2010,176:1256 - 1270.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部